[1]
S. Schmitz, “Dynamic Contrast-Enhanced Computed Tomography to Assess Early Activity of Cetuximab in Squamous Cell Carcinoma of the Head and Neck”, Radiol Oncol, vol. 49, no. 1, Feb. 2015.